Company Filing History:
Years Active: 2018-2024
Title: Christian Bacilieri: Innovator in Pharmaceutical Chemistry
Introduction
Christian Bacilieri is a notable inventor based in Breganzona, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of NK-1 antagonists. With a total of 5 patents to his name, Bacilieri's work is instrumental in advancing treatments for various medical conditions.
Latest Patents
Among his latest patents, Bacilieri has focused on crystalline forms of an NK-1 antagonist. This invention relates to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)propanamide. This compound is particularly useful in the treatment of induced vomiting and other related disorders. His innovative approach in this area showcases his commitment to improving patient outcomes through advanced pharmaceutical solutions.
Career Highlights
Christian Bacilieri is currently associated with Helsinn Healthcare SA, a company known for its focus on innovative cancer treatments and supportive care. His role at Helsinn has allowed him to collaborate with other experts in the field, further enhancing his contributions to pharmaceutical research and development.
Collaborations
Bacilieri has worked closely with his coworker, Gionata Frasca, to advance their research initiatives. Their collaboration has been pivotal in driving forward the development of new therapeutic agents.
Conclusion
Christian Bacilieri stands out as a prominent inventor in the pharmaceutical industry, with a focus on NK-1 antagonists that have the potential to transform treatment options for patients. His dedication to innovation and collaboration continues to make a significant impact in the field.